Ironwood Pharmaceuticals Inc (FRA:I76)
€ 4.54 -0.1 (-2.16%) Market Cap: 735.32 Mil Enterprise Value: 1.22 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 55/100

Ironwood Pharmaceuticals Inc at Barclays Global Healthcare Conference Transcript

Mar 14, 2019 / 06:05PM GMT
Release Date Price: €11.99 (+1.01%)
Geoffrey Christopher Meacham
Barclays Bank PLC, Research Division - MD & Senior Research Analyst

Geoff Meacham. I'm the senior biopharma analyst here, and we are thrilled to have Ironwood, Ironwood Pharmaceuticals. And speaking on behalf of Ironwood up on stage here is Mark Mallon, who is CEO; and then also Tom McCourt, who's Chief Commercial Officer. So Mark's going to give us just a few slides as a background, then we'll do a Q&A fireside chat here. Mark?

Mark Mallon
Ironwood Pharmaceuticals, Inc. - Executive Senior Adviser

All right. Thanks. Thanks, Geoff. And I'd like to thank Barclays and Geoff for the opportunity to speak here this afternoon at the conference. It's a very exciting time for Ironwood.

What I'll do is just very briefly give you an update on the spin-off and the split of the company with the launching of really 2 new companies, Ironwood and Cyclerion, and give you an update on how that process is going and then say a couple of words about Ironwood that Tom and I represent. Tom, as you've heard, is our President and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot